News

Cancer Research3d
No NIH Grants for Universities with DEI Programs, Israel Boycotts
The NIH will not award research grants to universities with diversity, equity, and inclusion (DEI) programs or boycotts of Israel, including those against Israeli companies or those that do business ...
Cancer Research4d
Abstract 4329: Developing oncogenic mutant-selective antisense oligonucleotide to treat PIK3CA-mutated cancers
Search for other works by this author on: ...
Cancer Research4d
Abstract 6417: Prostate cancer exploits neurolysin to modulate the tumor microenvironment and therapy resistance via KIF11-mediated WNT secretion
Search for other works by this author on: ...
Cancer Research4d
Abstract 1591: Mechanisms of BPM31510-induced cell death in cancer: lipid peroxidation and apoptosis pathways
Search for other works by this author on: ...
Cancer Research4d
Abstract 3503: ZW171, a differentiated 2+1 T cell-engaging bispecific antibody with antitumor activity in a range of mesothelin-expressing cancers
Zymeworks Inc., Vancouver, British Columbia, Canada.
Cancer Research4d
Abstract 1530: Elucidating the role of exogenous lipids in ferroptosis in castration resistant prostate cancer
Search for other works by this author on: ...
Cancer Research4d
Abstract 6331: Prevention of lung cancer growth by an edible mushroom-derived p-terphenyl antioxidant, Vialinin-A
Noorda College of Osteopathic Medicine, LLC, Provo, UT.
Cancer Research4d
Abstract 5389: Adaptive OXPHOS and antioxidant defense in glucose-deprivation-resistant colon cancer cells
Ariel University, Ari'el, Israel.
Cancer Research4d
Abstract 2025: Regulatory role of CDC20 phosphorylation in the onset and progression of endometrial carcinoma
Phosphorylation is a critical post-translational modification regulating key biological processes. CDC20 is a key regulator in cell cycle control, but its phosphorylation's role in Uterine Corpus ...
Cancer Research4d
Abstract 2211: A novel combined immunotherapy of gut microbial metabolite butyrate and oncolytic adenovirus in colorectal cancer
Butyrate, a short-chain fatty acid (SCFA) produced by gut bacteria in the colon, serves as a critical energy source for colonocytes. Gut microbiota and its primary metabolite, butyrate, have been ...
Cancer Research4d
Abstract 1733: XL495 is a potent, selective, and orally bioavailable inhibitor of PKMYT1
Cancer Res (2025) 85 (8_Supplement_1): 1733. Protein kinase, membrane-associated tyrosine/threonine-1 (PKMYT1) phosphorylates cyclin-dependent kinase 1 (CDK1) at threonine-14 (Thr14), inhibiting the ...
Cancer Research4d
Abstract 7427: Use of large language models for clinical data abstraction from oncologic medical records
Search for other works by this author on: ...